Asthma
Digital tool reduces ED visit rates for patients with asthma, Medicaid
ANAHEIM, Calif. — A digital asthma self-management program reduced ED visit rates for adults with asthma on Medicaid, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Q&A: Rademikibart may be ‘transformational therapy’ for moderate to severe asthma
Topline results from a phase 2b trial revealed that rademikibart led to improvements in lung function and asthma control in adults with moderate to severe persistent asthma compared with placebo.
Most-read FDA actions from 2023 in pulmonology
Healio Pulmonology has compiled the top news from the FDA posted in 2023.
Top asthma stories of 2023
This year’s asthma research covered a broad variety of topics, such as the effect of the family dog’s fur on long-term outcomes, asthma care in prison, fast food restaurants and the Canadian wildfires.
Reliever inhalers used more on days with high wildfire-related air pollution
ANAHEIM, Calif. —Patients with asthma used reliever inhalers more on days with unhealthy air quality during the Canadian wildfires, according to a poster at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Top 10 asthma, allergy stories of 2023
Innovation in asthma and allergy care continued in 2023. Healio’s most popular stories this year covered breakthroughs in immunotherapy treatments for food allergy and revised looks at common treatments for congestion and allergy.
Better communication, shared decision-making can improve outcomes
ANAHEIM, Calif. — Improvements in communication including shared decision-making can improve outcomes for patients with asthma, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Rademikibart improves lung function in moderate to severe asthma
Adults with moderate to severe persistent asthma receiving rademikibart every 2 weeks showed greater improvements in lung function at week 12 compared with patients assigned placebo, according to topline results from a phase 2b trial.
Asthma mortality rates higher in China than in the US, but the gap is closing
China had a higher asthma mortality rate than the United States between 1990 and 2019, driven by smoking, high BMI and age, but this gap narrowed with time, according to a study published in the Chinese Medical Journal.
Collaboration, technology may combat persistent disparities in asthma care
ANAHEIM, Calif. — Although disparities remain in asthma care, innovative strategies may close these gaps, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.